SeaCrest Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,430
| Closed | -$292K | – | 720 |
|
2022
Q2 | $292K | Buy |
1,430
+84
| +6% | +$17.2K | 0.04% | 472 |
|
2022
Q1 | $283K | Sell |
1,346
-49
| -4% | -$10.3K | 0.03% | 528 |
|
2021
Q4 | $335K | Sell |
1,395
-957
| -41% | -$230K | 0.04% | 476 |
|
2021
Q3 | $666K | Buy |
2,352
+58
| +3% | +$16.4K | 0.08% | 257 |
|
2021
Q2 | $794K | Buy |
+2,294
| New | +$794K | 0.1% | 228 |
|
2019
Q2 | – | Sell |
-390
| Closed | -$92K | – | 660 |
|
2019
Q1 | $92K | Buy |
390
+166
| +74% | +$39.2K | 0.02% | 717 |
|
2018
Q4 | $67K | Sell |
224
-644
| -74% | -$193K | 0.01% | 798 |
|
2018
Q3 | $307K | Sell |
868
-278
| -24% | -$98.3K | 0.05% | 382 |
|
2018
Q2 | $333K | Sell |
1,146
-644
| -36% | -$187K | 0.06% | 352 |
|
2018
Q1 | $490K | Buy |
1,790
+208
| +13% | +$56.9K | 0.09% | 241 |
|
2017
Q4 | $504K | Buy |
+1,582
| New | +$504K | 0.09% | 238 |
|